ArticleSurgical case reports2026
Coexisting Sarcoid Reaction and Sarcoidosis Requiring Differentiation from Pancreatic Adenocarcinoma Recurrence: A Case Report.
Article in Surgical case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionPancreatic ductal adenocarcinoma (PDAC) is one of the most severe malignant tumors. The recurrence rate is high, even after radical surgery. A sarcoid reaction is a histological finding that occurs in the lymph nodes in response to malignant tumors, infections, or foreign substances. Its histopathology is similar to that of sarcoidosis. Here, we report a case of coexisting sarcoid reaction and sarcoidosis that required differentiation from PDAC recurrence. CASE PRESENTATION: A 65-year-old woman was diagnosed with locally advanced PDAC. She underwent modified FOLFIRINOX (folinic acid, fluorouracil, irinotecan, and oxaliplatin) therapy for 6 months, after which the tumor shrunk, and there were no new metastatic lesions. Additionally, she underwent chemoradiation therapy (50 G/25 Fr and S-1), and a distal pancreatectomy with en bloc celiac axis resection and splenectomy were performed. Pathological diagnosis was PDAC, T2N0M0. Pathological findings of the regional lymph nodes showed no malignancy and noncaseating epithelioid cell granulomas, which were thought to be a sarcoid reaction. She received S-1 therapy for 6 months as adjuvant chemotherapy. On contrast-enhanced CT 1 year after the operation, enlarged para-aortic lymph nodes and multiple grainy pulmonary shadows were detected. Although recurrence was suspected, tumor marker levels did not increase. PET-CT revealed fluorodeoxyglucose accumulation in several lymph nodes, such as the para-aortic or neck, as well as in the bilateral femoral muscles. No accumulation was observed in the lung parenchyma. These findings were atypical of postoperative recurrence. Endoscopic ultrasonography-guided lymph nodes and body-surface ultrasonography-guided femoral muscle biopsies were performed. No malignancy was found in all the specimens, and noncaseating epithelioid cell granulomas were found.
conclusionsWhen enlarged lymph nodes are detected after surgery for a malignant tumor, we have to consider recurrence at first; however, it is important to make careful assessments because other factors are occasionally present.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.